Search for Clinical Trial Results

Sponsored By

Rhabdomyosarcoma, Alveolar - 10 Studies Found

Status Study
Recruiting Study Name: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
Condition:
  • Rhabdomyosarcoma
  • Rhabdomyosarcoma- Alveolar
  • Rhabdomyosarco
    Date: 2017-02-02
    Interventions:
    • Drug: Dasatinib Once daily on

Recruiting Study Name: A Two-Part Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
Condition: Relapsed or Refractory Medulloblastoma (MB) (Part A: Also Include Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS))
Date: 2016-04-08
Interventions:
  • Drug: TB-403 20mg/kg Up to 12

Suspended Study Name: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Condition:
  • Alveolar Rhabdomyosarcoma
  • Botryoid-Type Embryonal Rhabdomyosarc
    Date: 2015-10-02
    Interventions:
    • Drug: Cyclophosphamide Given I
Completed Study Name: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Condition:
  • Adult Rhabdomyosarcoma
  • Childhood Alveolar Rhabdomyosarcoma

    • Date: 2010-01-22
    Interventions:
    • Biological: Cixutumumab Given

Completed Study Name: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma
Condition:
  • Alveolar Childhood Rhabdomyosarcoma
  • Embryonal Childhood Rhabdomyosarcoma
  • Adult Rhabdomyosarcoma
  • Childhood Alveolar Rhabdomyosarcoma

    • Date: 2012-08-15
    Interventions: Other: Laboratory Biomarker Analysis Correlative studies
Completed Study Name: Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Condition:
  • Adult Rhabdomyosarcoma
  • Childhood Alveolar Rhabdomyosarcoma

    • Date: 2010-10-15
    Interventions:
    • Biological: Bevacizumab Given

Recruiting Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib
Condition:
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • Locally Advanced and/or Me
    Date: 2012-01-24
    Interventions: Drug: Crizotinib (PF-02341066) For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of
Active, not recruiting Study Name: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Condition:
  • Adult Malignant Mesenchymoma
  • Adult Rhabdomyosarcoma
  • Childh
    Date: 2006-07-19
    Interventions:
    • Drug: Irinotecan Hydrochloride

Active, not recruiting Study Name: Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Condition:
  • Carcinoid
  • Neuroendocrine

Date: 2006-04-13
Interventions: Drug: Seneca Valley Virus (biological agent) Dose escalation (starting at 1 × 10^7 vp/kg), IV (in t